It's also self-injectable and less painful than traditional implant options, according to research in rodents.

The USA compounding pharmacies market is poised for substantial growth, projected to reach USD 5,156.2 million in 2024, with a robust annual growth rate of 7.8% expected between 2024 and 2034. This ...